← European Medicine Shortage Tracker · all medicines
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
Adalimumab currently has availability issues reported in 4 European registers: Austria, Germany, Greece, Sweden.
Shortage ATC L04AB04 · also listed as: ADALIMUMAB · data refreshed 13 September 2026
As of 13 September 2026, 4 of the 9 tracked registers list current availability issues for Adalimumab, covering 5 affected product presentations. The longest-running open report was filed in Austria on 2025-07-17 and has now been open for about 14 months. The furthest expected-resolution date currently on file is 2026-10-16; the earliest is 2026-09-25. Notably, 2 reports have already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Momentum is current, not historical: 2 of the open reports were filed within the last 90 days. The issue spread across registers over time rather than at once: Austria reported first (2025-07-17), with Sweden following roughly 11 months later — a pattern typical of supply problems cascading between national markets. Registers in Germany, Sweden indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching. In the WHO ATC classification, Adalimumab is coded L04AB04 — a medicine acting on antineoplastic and immunomodulating agents — so clinically related products appear under “Related medicines” below.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇦🇹 Austria | Limited availability Hukyndra 40 mg Injektionslösung im Fertigpen | 2025-07-17 | — | — | register ↗ |
| 🇩🇪 Germany | Shortage Amsparity | 2025-11-01 | 2026-09-25 | Sonstige Alternatives: N/A | register ↗ |
| 🇬🇷 Greece | Limited availability μηχανισμό προστασίας βελόνας | 2026-05-13 | 2026-10-16 | Αυξημένη ζήτηση περιεκτικότητας Εναλλακτικά άλλα σκευάσματα της ίδιας | register ↗ |
| 🇸🇪 Sweden | Shortage Hukyndra 40 mg Injektionsvätska, lösning i förf. injektionspenna + 1 more productsHyrimoz 80 mg Injektionsvätska, lösning i förf. injektionspenna | 2026-06-19 | 2026-08-31 | — Alternatives: Alternative(s) available — see the national register. | register ↗ |
Every individual register entry for Adalimumab in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇸🇪 SE | Hukyndra 40 mg Injektionsvätska, lösning i förf. injektionspenna | Shortage | 2026-07-21 | 2026-08-31 | |
| 🇸🇪 SE | Hyrimoz 80 mg Injektionsvätska, lösning i förf. injektionspenna | Shortage | 2026-06-19 | 2026-08-19 | |
| 🇬🇷 GR | μηχανισμό προστασίας βελόνας | Limited availability | 2026-05-13 | 2026-10-16 | Αυξημένη ζήτηση περιεκτικότητας Εναλλακτικά άλλα σκευάσματα |
| 🇩🇪 DE | Amsparity | Shortage | 2025-11-01 | 2026-09-25 | Sonstige |
| 🇦🇹 AT | Hukyndra 40 mg Injektionslösung im Fertigpen | Limited availability | 2025-07-17 | — |
Yes. As of 13 September 2026, availability issues are reported in: Austria, Germany, Greece, Sweden. Availability is national — a shortage in one country does not mean it is short everywhere.
Agency prognoses on file range from 2026-09-25 to 2026-10-16. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.
3 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Adalimumab: BASG (Austria), BfArM (Germany), EOF limited-availability list (Greece), Läkemedelsverket (Sweden). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Adalimumab — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/adalimumab/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Adalimumab availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/adalimumab/">Adalimumab shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>